Bark, Inc. annual report, FY2022

BARK, Inc. — FY2022 Form 10-K Summary

Reporting period: Fiscal year ended March 31, 2022. Although the request metadata refers to “2021 Q4,” this filing reports full-year FY2022 results; it does not provide a clear standalone fourth-quarter financial summary. BARK sells dog products through direct-to-consumer subscriptions and retail/online commerce. Its June 2021 business combination was accounted for as a reverse recapitalization.

Key financial results

MetricFY2022FY2021
Revenue$507.4 million$378.6 million
Gross profit / gross margin$282.1 million / 55.6%$225.9 million / 59.7%
Operating loss$94.2 million$20.6 million
Net loss$68.3 million$31.4 million
Adjusted EBITDA loss (non-GAAP)$57.8 million$7.9 million
Cash used in operating activities$172.3 million$19.6 million
Cash and cash equivalents at year-end$199.4 million$38.3 million
Long-term debt, net of discount and fees$76.2 million$115.7 million

DTC generated $448.1 million, or 88.3% of revenue; Commerce generated $59.3 million, or 11.7%. The 2025 Convertible Notes had $79.2 million of principal outstanding at year-end, including accrued interest added to principal. The notes bear 5.50% interest payable in kind and mature December 1, 2025. There were no borrowings under the revolving credit facility at March 31, 2022. Current assets were $368.1 million and current liabilities were $108.6 million.

Changes versus the prior year

  • Revenue increased 34.0%, with DTC up 34.2% and Commerce up 32.9%. Subscription shipments rose 28.3% to 14.9 million, average order value increased 4.6% to $30.06, and active subscriptions reached 2.265 million.
  • Average monthly subscription shipment churn rose to 7.0% from 5.9%; customer acquisition cost increased to $53.43 from $47.55, while LTV:CAC declined to 4.7x from 6.3x.
  • Gross margin fell 4.1 percentage points, primarily due to inventory adjustments and write-downs, including the strategic narrowing of products, and higher inbound freight costs.
  • Operating expenses rose 52.6% to $376.3 million, outpacing revenue growth. General and administrative expense increased 68.2%, including higher fulfillment and shipping costs, compensation and stock-based compensation, and public-company audit and professional fees.
  • Operating cash use increased substantially, largely reflecting an $82.9 million increase in inventory and other working-capital movements. Capital expenditures were $21.2 million, compared with $4.8 million in FY2021.

Outlook, risks and unusual items

  • Management said cash, operating cash flows and available borrowings were expected to fund operations for at least the next 12 months. The filing provides no numerical revenue or profitability guidance. Management plans continued investment in products, marketing, fulfillment and new categories, including food and health.
  • Management cited freight inflation, demurrage fees and supply-chain disruption and expected these pressures to continue, with duration and magnitude uncertain. Other stated risks include customer acquisition and retention, competition, discretionary spending, supplier and logistics concentration, cybersecurity, and the ability to scale operations profitably.
  • FY2022 other income included $33.2 million of noncash warrant fair-value gains, materially reducing the reported net loss relative to the operating loss. Adjusted EBITDA loss was $57.8 million; the company’s non-GAAP adjustments included stock compensation, warrant fair-value changes, transaction costs, demurrage and other items.
  • Inventory was $153.1 million at year-end, with an $8.8 million excess and obsolete inventory reserve, up from $1.6 million. The auditor identified inventory reserve estimation as a critical audit matter.
  • Management reported material weaknesses in account reconciliation review, inventory controls, complex transaction accounting, and financial-system access, change management and segregation of duties. Management and the independent auditor concluded internal control over financial reporting was ineffective; the auditor issued an adverse opinion on ICFR. The auditor separately gave an unqualified opinion on the financial statements.
  • The company reported ordinary-course litigation and stated it did not believe pending matters would have a material adverse effect, while noting outcomes cannot be assured. A May 2022 amendment extended the revolving credit facility maturity to June 30, 2022.

Important facts for investors to verify

  • Whether cash burn and inventory levels can be reduced, and whether inventory reserves adequately reflect demand and obsolescence.
  • Progress in remediating the material weaknesses, particularly those affecting substantially all financial statement accounts.
  • Whether gross margin stabilizes as freight costs and inventory adjustments evolve, and whether operating expense growth moderates.
  • Subscription retention and acquisition economics, including churn, CAC and LTV:CAC, as new product categories and retail expansion develop.
  • Terms and repayment or conversion implications of the 2025 Convertible Notes, revolving credit facility availability and maturity, and potential dilution from notes, warrants, options and equity awards.